Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin

Journal of Maternal-Fetal Medicine

Volumn 9, Issue 4, 2000, Pages 209-215

  Parker C R , Jr ^a   Hauth, J C ^a   Goldenberg, R L ^a   Copper, R L ^a   Dubard, M B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Aspirin; Fetal growth; Newborn infant; Serum thromboxane B2

Indexed keywords

ACETYLSALICYLIC ACID; THROMBOXANE B2;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; ICOSANOID METABOLISM; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NEWBORN; PREECLAMPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UMBILICAL CORD BLOOD;

ADULT; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DELIVERY, OBSTETRIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL BLOOD; FETUS; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTERS; THROMBOXANE B2;

EID: 0033778903     PISSN: 10570802     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6661(200007/08)9:4<209::AID-MFM4>3.0.CO;2-S     Document Type: Article

References (23)

1. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth
2. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production
3. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants
4. Decreased prostacyclin biosynthesis preceeding the clinical manifestation of pregnancy-induced hypertension
5. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae
6. 2 to prostacyclin in relatively high risk pregnancies
7. Effects of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension
8. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets
9. Low-dose aspirin in pregnancy
10. Low-dose aspirin therapy to prevent preeclampsia
11. 2 reduction versus pregnancy outcome in a low-dose aspirin trial
12. Low-dose aspirin. I. Effects of angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II
13. Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome
14. Low-dose aspirin in hypertensive pregnant women: Effects on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn
15. Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans
16. 2 production in whole blood: The effects of maternal low dose aspirin
17. Low dose aspirin in pregnancy: A clinical and biochemical study of effects on the newborn
18. Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies
19. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency
20. Prevention of fetal growth retardation with low-dose aspirin: Findings of the EPREDA trial
21. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant woman
22. Prevention of preeclampsia with low-dose aspirin in healthy nulliparous pregnant women
23. Transfer of aspirin across the perfused human placental cotyledon